Business Wire reported that Researchers at the King Faisal Specialist Hospital and Research Centre in the Kingdom of Saudi Arabia and University Medical Center Hamburg (UMCH) have used Affymetrix microarray technology to discover a gene amplification associated with breast disease and breast cancer. The study, "Estrogen receptor alpha gene amplification is frequent in breast cancer," was published in a recent issue of Nature Genetics. "We introduced Affymetrix GeneChip Technology in the Kingdom of Saudi Arabia four years ago to help bridge the gap between laboratory findings and clinical application," said Khawla Al-Kuraya, M.D., F.C.A.P., a leading cancer researcher at KFSH&RC. "Since then, we have been able to investigate the etiology of a variety of tumors of different lineages to develop diagnostic or therapeutic strategies. Our overall goal is to improve the management of cancer in the Kingdom of Saudi Arabia and provide unprecedented tools for translational research throughout the region." --MORE
